A treatable immune-mediated neuropathy; immunoglobulin, steroids and a newer FcRn antagonist are used.
An autoimmune astrocytopathy distinct from multiple sclerosis; several targeted relapse-prevention therapies are approved.
Sign in to your account
Remember me
